In the BioHarmony Drug Report Database

"Preview" Icon

Mifamurtide

Mepact (mifamurtide) is a small molecule pharmaceutical. Mifamurtide was first approved as Mepact on 2009-03-06. It has been approved in Europe to treat osteosarcoma.

 

Trade Name

 

Mepact
 

Common Name

 

mifamurtide
 

ChEMBL ID

 

CHEMBL2107354
 

Indication

 

osteosarcoma
 

Drug Class

 

Peptides: peptides with muranic acid present

Image (chem structure or protein)

Mifamurtide structure rendering